StimCell Energetics Inc. (STME)

Market Cap	5.28M -43.1%
Revenue (ttm)	n/a
Net Income	-799.29K
EPS	-0.04
Shares Out	21.14M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200
Open	0.2499
Previous Close	0.16198
Day's Range	0.2499 - 0.2499
52-Week Range	0.1500 - 0.4800
Beta	46.00
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 20, 2026

About StimCell Energetics

StimCell Energetics Inc., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, metabolic syndrome, neuropathy, and kidney functions in the United States. It develops and manufactures the eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and the eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as th...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2010
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: STME

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 22, 2026

Data Sources Report a data error